Brinker Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$744K Sell
3,898
-7,975
-67% -$1.4M 0.02% 592
2020
Q1
$1.84M Sell
11,873
-3,046
-20% -$354K 0.07% 258
2019
Q4
$1.25M Buy
14,919
+25
+0.2% +$1.9K 0.04% 433
2019
Q3
$1.01M Buy
14,894
+2,060
+16% +$136K 0.03% 482
2019
Q2
$852K Buy
12,834
+3,562
+38% +$208K 0.03% 532
2019
Q1
$516K Buy
9,272
+4,899
+112% +$299K 0.02% 675
2018
Q4
$217K Buy
+4,373
New +$268K 0.01% 817

Other funds holding TDOC

Brinker Capital's TDOC Position: Q2 2020 in Review

Brinker Capital reduced its Teladoc Health (TDOC) stake by 67% in Q2 2020, selling an estimated $1.4M and leaving 3,898 shares worth $744K. The position accounts for 0.02% of the portfolio, ranked #592.

Brinker Capital first reported a position in TDOC in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.84M in Q1 2020. 670 funds tracked by Wall St. Rank hold TDOC as of Q2 2020.

  • Brinker Capital held 3,898 shares of Teladoc Health worth $744K as of Q2 2020.
  • Brinker Capital sold 7,975 Teladoc Health shares in Q2 2020, an estimated $1.4M.
  • Teladoc Health made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #592 holding.
  • Brinker Capital first reported a position in Teladoc Health in Q4 2018 and has held it in 7 quarters since.
  • Brinker Capital's Teladoc Health position peaked at $1.84M in Q1 2020.
  • 670 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.